Entasis Therapeutics Holdings (ETTX) Financials

$2.19

$0.00 (0.00%)

As on 11-Jul-2022 09:30EDT

Market cap

$105 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	7.00	5.00	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	7.00	5.00	--
Operating Expenses	92.00	52.32	50.67	51.64	37.87	29.95
Operating Profit (EBIT)	-55.57	-52.32	-54.23	-46.94	-38.21	-29.95
Other Income	0.01	--	0.17	1.46	0.39	--
Profit before Tax	-86.82	-47.14	-50.50	-43.17	-32.48	-29.92
Provision for Tax	--	--	--	0.68	0.47	--
Profit after Tax (Net Income)	-86.82	-47.14	-50.50	-43.85	-32.95	-29.92
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-51.70	-47.14	-50.50	-43.85	-42.09	-29.92

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	16.65	31.21	52.29	42.16	82.88	-55.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.30	--	0.70	1.32	0.18	104.75
Current Liabilities	24.14	9.71	8.57	7.56	6.22	9.83
Total Liabilities	68.23	40.92	61.56	51.03	89.27	58.79

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	4.21	1.11	1.43	2.03	0.48	2.47
Current Assets	39.88	39.82	60.13	49.01	88.79	56.32
Total Assets	68.23	40.92	61.56	51.03	89.27	58.79
Total Debt*	18.85	--	1.32	1.83	--	--
Net Current Assets	15.74	30.11	51.57	41.45	82.58	46.49

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-42.97	-45.43	-44.74	-35.82	-27.16
Cash Flow from Investing Activities	--	-0.07	24.98	11.36	-36.09	-0.29
Cash from Financing Activities	--	22.10	57.66	0.06	66.17	56.29
Net Cash Inflow / Outflow	--	--	37.21	-33.33	-5.74	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-1.97	-1.10	-2.10	-3.37	-10.98	--
Cash EPS ($)	--	-1.09	-2.10	-3.36	-10.93	--
Adjusted Book Value ($)	--	0.73	2.18	3.24	27.63	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.00	-1.89	-3.44	-11.94	--
Free Cash Flow per Share ($)	--	-1.00	-1.89	-3.45	-12.06	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-111.15	-103.48	-69.13	-243.25	72.86
ROE (%)	-300.00	-112.91	-106.93	-70.14	-243.25	72.86
ROA (%)	-134.51	-92.00	-89.70	-62.51	-44.51	-69.70
EBIT Margin (%)	--	--	--	-616.76	-649.60	--
Net Margin (%)	-1,447,066.67	--	-29,188.44	-518.14	-611.35	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	-1.00	0.40	--	--
EBIT Growth (%)	-100.07	-3.25	-17.36	-32.92	-8.45	-56.76
Net Profit Growth (%)	-89.03	6.64	-15.16	-33.07	-10.12	-56.71
EPS Growth (%)	-4.07	0.48	0.38	0.69	--	--
Book Value Growth (%)	-71.01	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-2.00	-1.17	-1.47	-0.37	--
Price / Book Value	6.30	3.02	1.13	1.53	0.15	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.75	-1.18	-0.15	-0.59	2.26	--
Close Price ($)	1.87	2.19	2.47	4.97	4.07	--
High Price ($)	3.88	3.88	5.64	9.25	13.70	--
Low Price ($)	1.40	1.76	1.58	3.97	4.02	--
Market Cap ($ Cr)	104.80	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	0.03	0.04	--	--
Short term debt to equity ratio	0.93	--	0.01	0.01	--	--
Current Ratio	1.65	4.10	7.02	6.49	14.28	5.73
Quick Ratio	1.65	--	--	--	--	--
Interest Coverage	-8,681.40	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	17.60	34.12	--
Asset Turnover	--	--	--	0.10	0.07	--
Receivable days	--	--	--	76.65	88.68	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.